{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:58Z","timestamp":1791216058010,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","award":["GZ-2017-11698"],"award-info":[{"award-number":["GZ-2017-11698"]}],"id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","award":["IIR-GBR-001662"],"award-info":[{"award-number":["IIR-GBR-001662"]}],"id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3425-1","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T14:03:04Z","timestamp":1559311384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2472-5538","authenticated-orcid":false,"given":"Ravi","family":"Vijapurapu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kozor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Woolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Rusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma A.","family":"Figtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Steeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"3425_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","volume":"51","author":"L Van der Tol","year":"2014","unstructured":"Van der Tol L, Smid BE, Poorthuis BJHM, Biegstraaten M, Deprez RHL, Linthorst GE, et al. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet. 2014;51:1\u20139.","journal-title":"J Med Genet"},{"key":"3425_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCGENETICS.116.001639","volume":"10","author":"B Adalsteinsdottir","year":"2017","unstructured":"Adalsteinsdottir B, Palsson R, Desnick RJ, Gardarsdottir M, Teekakirikul P, Maron M, et al. Fabry disease in families with hypertrophic cardiomyopathy: clinical manifestations in classic and later-onset phenotypes. Circ Cardiovasc Genet. 2017;10:1\u201310.","journal-title":"Circ Cardiovasc Genet"},{"key":"3425_CR3","doi-asserted-by":"crossref","unstructured":"Baig S, Vijapurapu R, Alharbi F, Nordin S, Kozor R, Moon J et al. Diagnosis and treatment of the cardiovascular consequences of Fabry disease. QJM. 2018; Epub ahead of print.","DOI":"10.1093\/qjmed\/hcy120"},{"key":"3425_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007;28:1228\u201335.","journal-title":"Eur Heart J"},{"key":"3425_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.beem.2014.10.003","volume":"29","author":"N Seydelmann","year":"2015","unstructured":"Seydelmann N, Wanner C, St\u00f6rk S, Ertl G, Weidemann F. Fabry disease and the heart. Best Pract Res Clin Endocrinol Metab. 2015;29:195\u2013204.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3425_CR6","first-page":"1","volume":"0","author":"S Baig","year":"2017","unstructured":"Baig S, Edwards N, Kotecha D, Liu B, Nordin S, Kozor R, et al. Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. Europace. 2017;0:1\u20139 Epub ahead of print.","journal-title":"Europace."},{"issue":"12","key":"3425_CR7","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/europace\/eur267","volume":"13","author":"C. O'Mahony","year":"2011","unstructured":"O'Mahony C, Coats C, Cardonna M, Garcia A, Calcagnini M, Murphy E et al. Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace. 2011;13(12):1781-8.","journal-title":"Europace"},{"key":"3425_CR8","doi-asserted-by":"crossref","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733\u201379.","DOI":"10.1093\/eurheartj\/ehu284"},{"issue":"3","key":"3425_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jelectrocard.2005.10.011","volume":"39","author":"Pamela K. Douglas","year":"2006","unstructured":"Douglas P, Batdorf N, Evans R, Feiveson A, Arenare B, Schlegel T. Temporal and postural variation of 12-lead high-frequency QRS electrocardiographic signals in asymptomatic individuals. J Electrocardiol. 2006;39:259\u201365.","journal-title":"Journal of Electrocardiology"},{"key":"3425_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jelectrocard.2006.03.004","volume":"39","author":"V Starc","year":"2006","unstructured":"Starc V, Schlegel T. Real-time multichannel system for beat-to-beat QT interval variability. J Electrocardiol. 2006;39:358\u201367.","journal-title":"J Electrocardiol"},{"issue":"3","key":"3425_CR11","doi-asserted-by":"publisher","first-page":"e0171069","DOI":"10.1371\/journal.pone.0171069","volume":"12","author":"Sarah Gleeson","year":"2017","unstructured":"Gleeson S, Liao Y, Dugo C, Cave A, Zhou L, Ayar Z et al. ECG-derived spatial QRS-T angle is associated with ICD implantation, mortality and heart failure admissions in patients with LV systolic dysfunction. PLoS One. 2017;12:e0171069.","journal-title":"PLOS ONE"},{"issue":"1","key":"3425_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jelectrocard.2016.11.003","volume":"50","author":"Ljuba Bacharova","year":"2017","unstructured":"Bacharova L, Estes H, Schocken D, Ugander M, Soliman E, Hill J et al. The 4th Report of the Working Group on ECG diagnosis of Left Ventricular Hypertrophy. J Electrocardiol. 2017;50:11\u20135.","journal-title":"Journal of Electrocardiology"},{"key":"3425_CR13","doi-asserted-by":"crossref","unstructured":"Schlegel T, Kulecz W, Feiveson A, Greco E, Depalma J, Starc V et al. Accuracy of advanced verses strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction. BMC Cardiovasc Disord. 2010;10:28.","DOI":"10.1186\/1471-2261-10-28"},{"issue":"16","key":"3425_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/heartjnl-2015-308897","volume":"102","author":"Christian Schmied","year":"2016","unstructured":"Schmied C, Nowak A, Gruner C, Olinger E, Debaix H, Brauchlin A et al. The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy. Heart. 2016;102:1309\u201314.","journal-title":"Heart"},{"key":"3425_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fcvm.2016.00007","volume":"3","author":"M Namdar","year":"2016","unstructured":"Namdar M. Electrocardiographic changes and arrhythmia in Fabry disease. Front Cardiovasc Med. 2016;3:7.","journal-title":"Front Cardiovasc Med"},{"key":"3425_CR16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","volume":"50","author":"TT Issac","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation. A systematic review of the published data. J Am Coll Cardiol. 2007;50:2021\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3425_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.hrthm.2009.12.009","volume":"7","author":"Jie Li","year":"2010","unstructured":"Li J, Solus J, Chen Q, Rho Y, Milne G, Stein C et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm. 2010;7:438\u201344.","journal-title":"Heart Rhythm"},{"issue":"15","key":"3425_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","volume":"68","author":"Sabrina Nordin","year":"2016","unstructured":"Nordin S, Kozor R, Bulluck H, Castelletti S, Rosmini S, Abdel-Gadir A et al. Cardiac Fabry disease with ate gadolinium enhancement is a chronic inflammatory cardiomyopathy. J Am Coll Cardiol. 2016;68:1707\u20138.","journal-title":"Journal of the American College of Cardiology"},{"key":"3425_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/08035320600618825","volume":"95","author":"M Beck","year":"2006","unstructured":"Beck M. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl. 2006;95:43\u20136.","journal-title":"Acta Paediatr Suppl"},{"key":"3425_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"3425_CR21","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1530\/ERP-14-0079","volume":"2","author":"G Wharton","year":"2015","unstructured":"Wharton G, Steeds R, Allen J, Phillips H, Jones R, Kanagala P, et al. A minimum dataset for ta standard adult transthoracic echocardiogram: a guideline protocol from the British Society of Echocardiography. Echo Res Pract. 2015;2:G9\u2013G24.","journal-title":"Echo Res Pract"},{"key":"3425_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.echo.2018.01.016","volume":"31","author":"DF Yeung","year":"2018","unstructured":"Yeung DF, Sirrs S, Tsang MYC, Gin K, Luong C, Jue J, et al. Echocardiographic assessment of patients with Fabry disease. J Am Soc Echocardiogr. 2018;31:639\u201349.","journal-title":"J Am Soc Echocardiogr"},{"key":"3425_CR23","doi-asserted-by":"crossref","unstructured":"Nagueh A, Smiseth O, Appleton C, Byrd B, Dokainish H, Edvardsen T et al. ASE\/EACVI Guidelines and Standards. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314.","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"3425_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2011.01.015","volume":"24","author":"V Mor-Avi","year":"2011","unstructured":"Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications. Endorsed by the Japanese Society of echocardiography. J Am Soc Echocardiogr. 2011;24:277\u2013313.","journal-title":"J Am Soc Echocardiogr"},{"key":"3425_CR25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.26442\/2075-1753_2015.1.22-26","volume":"17","author":"R Kozor","year":"2015","unstructured":"Kozor R, Callaghan F, Tchan M, Hamilton-Craig C, Figtree GA, Grieve SM. A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease. JCMR. 2015;17:22.","journal-title":"JCMR."},{"key":"3425_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2261-10-28","volume":"10","author":"T Schlegel","year":"2010","unstructured":"Schlegel T, Kulecz W, Feiveson A, Greco E, DePalma J, Starc V, et al. Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction. BMC Cardiovasc Dis. 2010;10:28\u201339.","journal-title":"BMC Cardiovasc Dis"},{"key":"3425_CR27","doi-asserted-by":"crossref","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO) 2016.","DOI":"10.5603\/KP.2016.0172"},{"key":"3425_CR28","unstructured":"Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281\u2013329."},{"issue":"6","key":"3425_CR29","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","volume":"96","author":"Jaymin S. Shah","year":"2005","unstructured":"Shah J, Hughes D, Sachdev B, Tome M, Ward D, Lee P et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005;96:842\u20136.","journal-title":"The American Journal of Cardiology"},{"issue":"12","key":"3425_CR30","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/heartjnl-2014-306782","volume":"101","author":"Vimal Patel","year":"2015","unstructured":"Patel V, O'Mahony C, Hughes D, Rahman M, Coats C, Murphy E et al. Clinical and genetic predictors of major cardiac events in patients with Anderson\u2013Fabry Disease. Heart. 2015;101:961\u20136.","journal-title":"Heart"},{"issue":"6","key":"3425_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","volume":"114","author":"Johannes Kr\u00e4mer","year":"2014","unstructured":"Kramer J, Niemann M, Stork S, Frantz S, Beer M, Ertl G et al. Relation of Burden of Myocardial Fibrosis to Malignant Ventricular Arrhythmias and Outcomes in Fabry Disease. Am J Cardiol. 2014;114:895\u2013900.","journal-title":"The American Journal of Cardiology"},{"key":"3425_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.15420\/AER.2016.17.2","volume":"5","author":"A Galli","year":"2016","unstructured":"Galli A, Ambrosini F, Lombardi F. Holter monitoring and loop recorders: from research to clinical practice. Arrhyth Electrophysiol Rev. 2016;5:136\u201343.","journal-title":"Arrhyth Electrophysiol Rev"},{"issue":"4","key":"3425_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/joim.12077","volume":"274","author":"F. Weidemann","year":"2013","unstructured":"Weidemann F, Niemann M, Stork S, Breunig F, Beer M, Sommer C et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med. 2013;274:331\u201341.","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"3425_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.amjcard.2016.04.033","volume":"118","author":"Frank Weidemann","year":"2016","unstructured":"Weidemann F, Maier S, Stork S, Brunner T, Liu D, Hu K et al. Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced Fabry cardiomyopathy. Am J Cardiol. 2016;118:264\u201374.","journal-title":"The American Journal of Cardiology"},{"issue":"Suppl 1","key":"3425_CR35","first-page":"ehy564.P1017","volume":"39","author":"R Vijapurapu","year":"2018","unstructured":"Vijapurapu R, Baig S, Wheeldon N, Hughes D, Jovanovic A, Woolfson P, et al. A national study evaluating cardiac device implantation and usage in patients with Fabry disease. Eur Heart J. 2018;39(Suppl 1):ehy564.P1017.","journal-title":"Eur Heart J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3425-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3425-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3425-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T15:38:07Z","timestamp":1608133087000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3425-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3425"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3425-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was granted ethical approval by the NHS Health Research Authority and local NHS Research Ethics Committee (Integrated Research Application System project code 224749, REC reference 17\/WM\/0421) and the Human Research Ethics Committee of the Northern Sydney Local Health District (HREC Reference: HREC\/18\/HAWKE\/27). The study is registered on ClinicalTrials.gov (NCT03305250). The study protocol version 3.0 has been granted ethical approval by the above-mentioned regulatory bodies. Informed consent will be obtained in accordance with Good Clinical Practice guidelines, and all participants will be provided with a patient information sheet to review prior to consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"By providing informed consent for participation in this study, all participants agree to have study results published in clinical meetings and scientific journal articles. Data will be anonymised prior to analysis and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RK has received honoraria from Sanofi-Genzyme. DH has received honoraria from Shire, Sanofi-Genzyme and Amicus. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}